Ceradyne (CRDN) Reports Q4 EPS of $1.28; Lowers FY08 Outlook

February 26, 2008 8:05 AM EST Send to a Friend
Ceradyne Inc. (Nasdaq: CRDN) reports Q4 EPS of $1.28, 2 cents worse than the analyst estimate of $1.30. Revenues ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login